Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page
- ChecktodayChange DetectedDifference0.2%
- Check7 days agoChange DetectedThe web page has removed significant content regarding a Phase Ib/II study on idasanutlin for treating acute myeloid leukemia, including detailed study descriptions and inclusion/exclusion criteria, while adding a new EudraCT number and a revision number.SummaryDifference10%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check29 days agoChange DetectedDifference0.1%
- Check44 days agoChange DetectedDifference0.1%
Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.